Mouse Anti-GOSR2 Recombinant Antibody (99) (CBMAB-AP2584LY)

Aburayyan, A., Carlson, R. J., Rabie, G. N., Lee, M. K., Gulsuner, S., Walsh, T., ... & King, M. C. (2023). Low level of GOSR2 translation from a non-AUG start codon in a family with profound hearing loss. Human molecular genetics, ddad066.

Henige, H., Kaur, S., & Pappas, K. (2021). Compound heterozygous variants in GOSR2 associated with congenital muscular dystrophy: A case report. European Journal of Medical Genetics, 64(4), 104184.

Stemmerik, M. G., Borch, J. D. S., Dunø, M., Krag, T., & Vissing, J. (2021). Myopathy can be a key phenotype of membrin (GOSR2) deficiency. Human Mutation, 42(9), 1101-1106.

Offerhaus, J., Podliesna, S., Verkerk, A. O., Marchal, G., Lodder, L. E., Boukens, B. J. B., ... & Bezzina, C. R. (2020). Membrin/GOSR2 is a novel NaV1. 5-interacting protein modulating cardiac conduction. European Heart Journal, 41(Supplement_2), ehaa946-3598.

Jepson, J. E., Praschberger, R., & Krishnakumar, S. S. (2019). Mechanisms of neurological dysfunction in GOSR2 progressive myoclonus epilepsy, a golgi SNAREopathy. Neuroscience, 420, 41-49.

Praschberger, R. (2018). Expanding the mutational spectrum and investigating the pathophysiology of GOSR2 mediated progressive myoclonus epilepsy (Doctoral dissertation, UCL (University College London)).

Larson, A. A., Baker, P. R., Milev, M. P., Press, C. A., Sokol, R. J., Cox, M. O., ... & Moore, S. A. (2018). TRAPPC11 and GOSR2 mutations associate with hypoglycosylation of α-dystroglycan and muscular dystrophy. Skeletal muscle, 8(1), 1-10.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols